Nuvation Bio Inc. (NUVB)
Nuvation Bio Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for serious diseases, particularly in the fields of oncology and rare genetic disorders. The company is dedicated to discovering and advancing novel treatments that address unmet medical needs through targeted research and development efforts.
Company News
U.S. stock futures were lower this morning, with the Nasdaq futures falling by around 0.2% on Wednesday. Shares of Intel Corporation (NASDAQ: INTC) fell sharply in today’s pre-market trading after the company outlined a new financial framework for its foundry business. After the market close on Tuesday, Intel announced a new financial reporting structure designed to drive increased cost discipline and higher returns by providing greater transparency, accountability and incentives across the business. Intel shares dipped 4.8% to $41.85 in pre-market trading. Here are some big stocks recording losses in today’s pre-market trading session. Mesoblast Limited (NASDAQ:
Does Nuvation Bio Inc. (NUVB) have what it takes to be a top stock pick for momentum investors? Let's find out.